CRISPR/Cas9-Based Therapeutic Strategies for Alzheimer’s Disease: Current Advances and Future Perspectives
Alzheimer’s disease (AD) is the leading cause of neurodegenerative dementia and represents a significant worldwide health burden. The disease is marked by a gradual deterioration of cognitive abilities, which is closely linked to the accumulation of amyloid-β (Aβ), the development of tau-related pathology, impaired syn...